Found 242 chains in Knotoided chains table. Displaying 1 - 150. Applied filters: Probabilistic

Search results query: topological notation for knotoids: K 2.1

Hide raw data panel
#pdbid|chain|deposition date|is S/K-not|(slip)knot types;
      
  7e3s|A|2022-05-11|K|2.1;
  7e3q|A|2022-05-11|K|2.1;
  7d51|A|2021-11-23|K|2.1;
  7mu3|A|2021-10-05|K|2.1;
  6zr9|A|2021-07-16|K|2.1;
  6yma|A|2020-08-23|K|2.1;
  6ufd|A|2020-08-22|K|2.1;
  6ufc|A|2020-08-22|K|2.1;
  6km6|A|2020-08-20|K|2.1;
  6wq7|A|2020-08-06|K|2.1;
  6wq8|A|2020-08-06|K|2.1;
  6otk|A|2020-08-04|K|2.1;
  6oti|A|2020-08-04|K|2.1;
  6oum|A|2020-08-04|K|2.1;
  6oue|A|2020-08-04|K|2.1;
  6rg3|A|2020-08-04|K|2.1;
  6s03|A|2020-08-04|K|2.1;
  6ux1|A|2020-04-30|K|2.1;
  6r6j|A|2020-04-17|K|2.1;
  6rxz|CN|2020-04-09|K|2.1;
  6qut|A|2020-04-09|K|2.1;
  6i0j|A|2019-11-28|K|2.1;
  6i0l|A|2019-11-28|K|2.1;
  6qfv|A|2019-05-08|K|2.1;
  6qfx|A|2019-05-08|K|2.1;
  6qfu|A|2019-05-08|K|2.1;
  6qfw|A|2019-05-08|K|2.1;
  6qeb|A|2019-03-22|K|2.1;
  6h2z|A|2019-01-09|K|2.1;
  6h34|A|2019-01-09|K|2.1;
  6h33|A|2019-01-09|K|2.1;
  6g3v|A|2018-12-02|K|2.1;
  12ca|A|2018-10-21|K|2.1;
  5e2m|A|2018-10-21|K|2.1;
  6evr|A|2018-10-21|K|2.1;
  1azm|A|2018-10-21|K|2.1;
  1cvb|A|2018-10-20|K|2.1;
  7ca2|A|2018-10-20|K|2.1;
  3mwo|A|2018-10-20|K|2.1;
  1ydd|A|2018-10-20|K|2.1;
  1huh|A|2018-10-20|K|2.1;
  1hug|A|2018-10-20|K|2.1;
  3p44|A|2018-10-20|K|2.1;
  3bl1|A|2018-10-20|K|2.1;
  4g7a|A|2018-10-20|K|2.1;
  3w6i|A|2018-10-20|K|2.1;
  1cve|A|2018-10-20|K|2.1;
  1hcb|A|2018-10-20|K|2.1;
  4mty|A|2018-10-20|K|2.1;
  5tfx|A|2018-10-20|K|2.1;
  4l5v|A|2018-10-20|K|2.1;
  3kkx|A|2018-10-20|K|2.1;
  4pq7|A|2018-10-20|K|2.1;
  1rj5|A|2018-10-20|K|2.1;
  2fw4|A|2018-10-20|K|2.1;
  1bnq|A|2018-10-20|K|2.1;
  2eu3|A|2018-10-20|K|2.1;
  2weh|A|2018-10-20|K|2.1;
  3f4x|A|2018-10-20|K|2.1;
  3ieo|A|2018-10-20|K|2.1;
  4m2w|A|2018-10-20|K|2.1;
  4ywp|A|2018-10-20|K|2.1;
  4q08|A|2018-10-20|K|2.1;
  4xix|A|2018-10-20|K|2.1;
  1j9w|A|2018-10-20|K|2.1;
  5ty1|A|2018-10-20|K|2.1;
  5ehe|A|2018-10-20|K|2.1;
  5ogj|A|2018-10-20|K|2.1;
  4bcw|A|2018-10-20|K|2.1;
  1ccs|A|2018-10-20|K|2.1;
  3t82|A|2018-10-19|K|2.1;
  1uga|A|2018-10-19|K|2.1;
  1fqr|A|2018-10-19|K|2.1;
  3ni5|A|2018-10-19|K|2.1;
  1bnw|A|2018-10-19|K|2.1;
  4e4a|A|2018-10-19|K|2.1;
  5n1s|A|2018-10-19|K|2.1;
  5cac|A|2018-10-19|K|2.1;
  5tya|A|2018-10-19|K|2.1;
  2pov|A|2018-10-19|K|2.1;
  4wl4|A|2018-10-19|K|2.1;
  4ito|A|2018-10-19|K|2.1;
  3v3j|A|2018-10-19|K|2.1;
  4fl7|A|2018-10-19|K|2.1;
  1koq|A|2018-10-19|K|2.1;
  1cvh|A|2018-10-19|K|2.1;
  2it4|A|2018-10-19|K|2.1;
  1g6v|A|2018-10-19|K|2.1;
  1rj6|A|2018-10-19|K|2.1;
  1cct|A|2018-10-19|K|2.1;
  1bnu|A|2018-10-19|K|2.1;
  3m2z|A|2018-10-19|K|2.1;
  6bcc|A|2018-10-19|K|2.1;
  1dcb|A|2018-10-19|K|2.1;
  4frc|A|2018-10-19|K|2.1;
  1oq5|A|2018-10-19|K|2.1;
  4e3d|A|2018-10-19|K|2.1;
  4pxx|A|2018-10-19|K|2.1;
  4r5b|A|2018-10-19|K|2.1;
  3dcs|A|2018-10-19|K|2.1;
  2cab|A|2018-10-19|K|2.1;
  4q6d|A|2018-10-19|K|2.1;
  5u0e|A|2018-10-19|K|2.1;
  1dca|A|2018-10-19|K|2.1;
  4qjx|A|2018-10-18|K|2.1;
  5gmm|A|2018-10-18|K|2.1;
  4yvy|A|2018-10-18|K|2.1;
  5n0d|A|2018-10-18|K|2.1;
  1cva|A|2018-10-18|K|2.1;
  1cil|A|2018-10-18|K|2.1;
  1tg9|A|2018-10-18|K|2.1;
  1hec|A|2018-10-18|K|2.1;
  1cvc|A|2018-10-18|K|2.1;
  1yo1|A|2018-10-18|K|2.1;
  2nxs|A|2018-10-18|K|2.1;
  1ydb|A|2018-10-18|K|2.1;
  2nxr|A|2018-10-18|K|2.1;
  3t84|A|2018-10-18|K|2.1;
  4z1j|A|2018-10-18|K|2.1;
  4y0j|A|2018-10-18|K|2.1;
  1fr7|A|2018-10-18|K|2.1;
  1crm|A|2018-10-18|K|2.1;
  1flj|A|2018-10-18|K|2.1;
  1cnw|A|2018-10-18|K|2.1;
  4q06|A|2018-10-18|K|2.1;
  2nn7|A|2018-10-18|K|2.1;
  3m5s|A|2018-10-18|K|2.1;
  3m1w|A|2018-10-18|K|2.1;
  1cvd|A|2018-10-18|K|2.1;
  6d1m|A|2018-10-18|K|2.1;
  1fsr|A|2018-10-18|K|2.1;
  4m2v|A|2018-10-18|K|2.1;
  4k1q|A|2018-10-18|K|2.1;
  1cny|A|2018-10-18|K|2.1;
  1a42|A|2018-10-18|K|2.1;
  3v3g|B|2018-10-18|K|2.1;
  3hfp|A|2018-10-18|K|2.1;
  1cnc|A|2018-10-18|K|2.1;
  2nwz|A|2018-10-18|K|2.1;
  4hf3|A|2018-10-18|K|2.1;
  3tvo|X|2018-10-18|K|2.1;
  2q38|A|2018-10-18|K|2.1;
  3kig|A|2018-10-18|K|2.1;
  3m2y|A|2018-10-18|K|2.1;
  8ca2|A|2018-10-17|K|2.1;
  3da2|A|2018-10-17|K|2.1;
  4yyt|A|2018-10-17|K|2.1;
  4yxo|A|2018-10-17|K|2.1;
  2h15|A|2018-10-17|K|2.1;
  1cim|A|2018-10-17|K|2.1;
  3mdz|A|2018-10-17|K|2.1;
  4lp6|A|2018-10-17|K|2.1;
  6f3b|A|2018-10-12|K|2.1;
  6ex1|A|2018-10-12|K|2.1;
  6fag|A|2018-10-12|K|2.1;
  4kap|A|2018-10-03|K|2.1;
  4q9y|A|2018-10-03|K|2.1;
  1ca2|A|2018-10-03|K|2.1;
  2nwy|A|2018-10-03|K|2.1;
  1heb|A|2018-10-03|K|2.1;
  1hed|A|2018-10-03|K|2.1;
  1hca|A|2018-10-03|K|2.1;
  2ca2|A|2018-10-03|K|2.1;
  1if5|A|2018-10-03|K|2.1;
  1ydc|A|2018-10-03|K|2.1;
  6ca2|A|2018-10-03|K|2.1;
  2o4z|A|2018-10-02|K|2.1;
  3t85|A|2018-10-02|K|2.1;
  3rz0|B|2018-10-02|K|2.1;
  3b4f|A|2018-10-02|K|2.1;
  3ca2|A|2018-10-02|K|2.1;
  3f8e|A|2018-10-02|K|2.1;
  1yda|A|2018-10-01|K|2.1;
  3ffp|X|2018-10-01|K|2.1;
  3okv|A|2018-10-01|K|2.1;
  3kok|A|2018-10-01|K|2.1;
  1kop|A|2018-09-29|K|2.1;
  5dsn|A|2018-09-26|K|2.1;
  5l6k|A|2018-06-12|K|2.1;
  5llg|A|2018-06-12|K|2.1;
  5lln|A|2018-06-12|K|2.1;
  5nxw|A|2018-06-12|K|2.1;
  9ca2|A|2018-06-12|K|2.1;
  5ipz|A|2018-06-12|K|2.1;
  1cnh|A|2018-06-11|K|2.1;
  1czm|A|2018-06-11|K|2.1;
  1fqm|A|2018-06-11|K|2.1;
  1fsn|A|2018-06-11|K|2.1;
  1lg5|A|2018-06-11|K|2.1;
  1mxc|A|2018-06-11|K|2.1;
  1o90|A|2018-06-11|K|2.1;
  2hfy|A|2018-06-11|K|2.1;
  2obv|A|2018-06-11|K|2.1;
  3caj|A|2018-06-11|K|2.1;
  3d8w|A|2018-06-11|K|2.1;
  3dd8|A|2018-06-11|K|2.1;
  3f7b|A|2018-06-11|K|2.1;
  3f7u|A|2018-06-11|K|2.1;
  3fw3|A|2018-06-11|K|2.1;
  3ibl|A|2018-06-11|K|2.1;
  3iml|A|2018-06-11|K|2.1;
  3jxg|A|2018-06-11|K|2.1;
  3jxh|C|2018-06-11|K|2.1;
  3kld|B|2018-06-11|K|2.1;
  3m2n|A|2018-06-11|K|2.1;
  3m3x|A|2018-06-11|K|2.1;
  3m67|A|2018-06-11|K|2.1;
  3mhl|A|2018-06-11|K|2.1;
  3mho|A|2018-06-11|K|2.1;
  3nk6|A|2018-06-11|K|2.1;
  3po6|A|2018-06-11|K|2.1;
  3pyk|A|2018-06-11|K|2.1;
  3rv2|A|2018-06-11|K|2.1;
  3ryy|A|2018-06-11|K|2.1;
  3rz8|A|2018-06-11|K|2.1;
  3so4|A|2018-06-11|K|2.1;
  3tmj|A|2018-06-11|K|2.1;
  3u47|A|2018-06-11|K|2.1;
  3znc|A|2018-06-11|K|2.1;
  4bf6|A|2018-06-11|K|2.1;
  4etq|C|2018-06-11|K|2.1;
  4gge|A|2018-06-11|K|2.1;
  4ktv|C|2018-06-11|K|2.1;
  4ktv|D|2018-06-11|K|2.1;
  4le5|A|2018-06-11|K|2.1;
  4ndn|B|2018-06-11|K|2.1;
  4ndn|C|2018-06-11|K|2.1;
  5dog|A|2018-06-11|K|2.1;
  5e5r|A|2018-06-11|K|2.1;
  5e5u|A|2018-06-11|K|2.1;
  5g03|A|2018-06-11|K|2.1;
  5jn8|A|2018-06-11|K|2.1;
  5jna|A|2018-06-11|K|2.1;
  5jnc|A|2018-06-11|K|2.1;
  5ku6|A|2018-06-11|K|2.1;
  5sz2|A|2018-06-11|K|2.1;
  5sz3|A|2018-06-11|K|2.1;
  5sz7|A|2018-06-11|K|2.1;
  5thj|A|2018-06-11|K|2.1;
  1znc|A|2018-06-11|K|2.1;
  1bcd|A|2018-06-10|K|2.1;
  1bic|A|2018-06-10|K|2.1;

      
Knotoid types pdb Title
K 2.1 7e3sA Crystal structure of trml from shewanella oneidensis
K 2.1 7e3qA Crystal structure of sah bound trml from vibrio vulnificus
K 2.1 7d51A Crystal structure of a truly knotted protein: cyclized yibk from haemophilus influenzae
K 2.1 7mu3A Human carbonic anhydrase 9 mimic with compound
K 2.1 6zr9A The crystal structure of the complex of hcavii with 2-(4-benzhydrylpiperazin-1-yl)-n-(4-sulfamoylphenyl)acetamide
K 2.1 6ymaA Microed structure of acetazolamide-bound human carbonic anhydrase ii
K 2.1 6ufdA Carbonic anhydrase 2 with inhibitor (2z)-3-oxo-n-(4-sulfamoylphenyl)-2-[(thiophen-2-yl)methylidene]butanamide (11g/d7)
K 2.1 6ufcA Carbonic anhydrase 2 with inhibitor (2z)-2-[(4-methoxyphenyl)methylidene]-3-oxo-n-(4-sulfamoylphenyl)butanamide (11d/d4)
K 2.1 6km6A Human carbonic anhydrase ii native 15 atm co2
K 2.1 6wq7A Carbonic anhydrase ii complexed with 2-((3-aminopropyl)(phenethyl)amino)-n-(4-fluorobenzyl)-n-(4-sulfamoylphenethyl)acetamide
K 2.1 6wq8A Carbonic anhydrase ii complexed with 3-((2-((furan-2-ylmethyl)(4-sulfamoylphenethyl)amino)-2-oxoethyl)(phenethyl)amino)propanoic acid
K 2.1 6otkA Carbonic anhydrase ix mimic complexed with ureido benzene sulfonamide mb10-596b
K 2.1 6otiA Carbonic anhydrase ix mimic complexed with ureic benzene sulfonamide mb9-561b
K 2.1 6oumA Carbonic anhydrase ix mimic complexed with benzene sulfonamide mb10-580b
K 2.1 6oueA Carbonic anhydrase ii complexed with benzene sulfonamide mb11-707a
K 2.1 6rg3A Crystal structure of human carbonic anhydrase ii in complex with (r)-4-(2-benzylpiperazin-1-yl)benzenesulfonamide
K 2.1 6s03A Carbonic anhydrase caix mimic in complex with inhibitor i39lt379
K 2.1 6ux1A Carbonic anhydrase ii complexed with salicylic acid
K 2.1 6r6jA Crystal structure of human carbonic anhydrase isozyme ii with 2-(benzenesulfonyl)-4-chloro-n-(2-hydroxyethyl)-5-sulfamoyl-benzamide
K 2.1
1
6rxzCN Cryo-em structure of the 90s pre-ribosome (kre33-noc4) from chaetomium thermophilum, state b
K 2.1 6qutA Three dimensional structure of human carbonic anhydrase ix in complex with benzenesulfonamide
K 2.1 6i0jA Crystal structure of human carbonic anhydrase i in complex with the 4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl sulfamate inhibitor
K 2.1 6i0lA Crystal structure of human carbonic anhydrase i in complex with the 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[2-(4-sulfamoylphenyl)ethyl]urea inhibitor
K 2.1 6qfvA Human carbonic anhydrase ii with bound ircp* complex (cofactor 8) to generate an artificial transfer hydrogenase (athase)
K 2.1 6qfxA Human carbonic anhydrase ii with bound ircp* complex (cofactor 10) to generate an artificial transfer hydrogenase (athase)
K 2.1 6qfuA Human carbonic anhydrase ii with bound ircp* complex (cofactor 7) to generate an artificial transfer hydrogenase (athase)
K 2.1 6qfwA Human carbonic anhydrase ii with bound ircp* complex (cofactor 9) to generate an artificial transfer hydrogenase (athase)
K 2.1 6qebA Assessment of a large enzyme-drug complex by proton-detected solid-state nmr without deuteration
K 2.1 6h2zA The crystal structure of human carbonic anhydrase ii in complex with 4-(4-phenylpiperidine-1-carbonyl)benzenesulfonamide.
K 2.1 6h34A The crystal structure of human carbonic anhydrase ii in complex with 4-[(4-fluorophenyl)methyl]-1-piperazinyl]benzenesulfonamide.
K 2.1 6h33A The crystal structure of human carbonic anhydrase ii in complex with 4-(4-phenyl)-4-hydroxy-1-piperidine-1-carbonyl)benzenesulfonamide.
K 2.1 6g3vA Crystal structure of human carbonic anhydrase i in complex with the inhibitor famotidine
K 2.1 12caA Altering the mouth of a hydrophobic pocket. structure and kinetics of human carbonic anhydrase ii mutants at residue val-121
K 2.1 5e2mA Crystal structure of human carbonic anhydrase isozyme i with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
K 2.1 6evrA Crystal structure of human carbonic anhydrase i in complex with the 4-(4 acetyl-3-benzylpiperazine-1 carbonyl)benzene-1-sulfonamide inhibitor
K 2.1 1azmA Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i
K 2.1 1cvbA Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase ii
K 2.1 7ca2A Engineering the hydrophobic pocket of carbonic anhydrase ii
K 2.1 3mwoA Human carbonic anhydrase ii in a doubled monoclinic cell: a re-determination
K 2.1 1yddA Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii
K 2.1 1huhA Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes
K 2.1 1hugA Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes
K 2.1 3p44A Human carbonic anhydrase ii in complex with p-(4-ruthenocenyl-1h-1,2,3-triazol-1-yl)benzenesulfonamide
K 2.1 3bl1A Carbonic anhydrase inhibitors. sulfonamide diuretics revisited old leads for new applications
K 2.1 4g7aA The crystal structure of an alpha carbonic anhydrase from the extremophilic bacterium sulfurihydrogenibium yellowstonense yo3aop1
K 2.1 3w6iA Crystal structure of 19f probe-labeled hcai
K 2.1 1cveA Structural consequences of redesigning a protein-zinc binding site
K 2.1 1hcbA Enzyme-substrate interactions: structure of human carbonic anhydrase i complexed with bicarbonate
K 2.1 4mtyA Structure at 1a resolution of a helical aromatic foldamer-protein complex.
K 2.1 5tfxA New method for synthesis of benzoxazole amide inhibitors of carbonic anhydrase
K 2.1 4l5vA The structural implications of the secondary co2 binding pocket in human carbonic anhydrase ii
K 2.1 3kkxA Neutron structure of human carbonic anhydrase ii
K 2.1 4pq7A The crystal structure of the human carbonic anhydrase ii in complex with a sulfamide inhibitor
K 2.1 1rj5A Crystal structure of the extracellular domain of murine carbonic anhydrase xiv
K 2.1 2fw4A Carbonic anhydrase activators. the first x-ray crystallographic study of an activator of isoform i, structure with l-histidine.
K 2.1 1bnqA Carbonic anhydrase ii inhibitor
K 2.1 2eu3A Human carbonic anhydrase ii in complex with novel inhibitors
K 2.1 2wehA Thermodynamic optimisation of carbonic anhydrase fragment inhibitors
K 2.1 3f4xA Carbonic anhydrase inhibitors. comparison of chlorthalidone and indapamide x-ray crystal structures in adducts with isozyme ii: when three water molecules make the difference
K 2.1 3ieoA The coumarin-binding site in carbonic anhydrase: the antiepileptic lacosamide as an example
K 2.1 4m2wA Genetically engineered carbonic anhydrase ix in complex with dorzolamide
K 2.1 4ywpA Sucrose binding site in genetically engineered carbonic anhydrase ix
K 2.1 4q08A Crystal structure of chimeric carbonic anhydrase xii with inhibitor
K 2.1 4xixA Carbonic anhydrase cah3 from chlamydomonas reinhardtii in complex with phosphate.
K 2.1 1j9wA Solution structure of the cai michigan 1 variant
K 2.1 5ty1A Identification of a new zinc binding chemotype by fragment screening
K 2.1 5eheA Crystal structure of human carbonic anhydrase isozyme ii with 3-(benzylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
K 2.1 5ogjA Crystal structure of human carbonic anhydrase isozyme xiii with 2-(cyclooctylamino)-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide
K 2.1 4bcwA Carbonic anhydrase ix mimic in complex with (e)-2-(5-bromo-2- hydroxyphenyl)ethenesulfonic acid
K 2.1 1ccsA Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity
K 2.1 3t82A Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
K 2.1 1ugaA Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by phe (a65f)
K 2.1 1fqrA X-ray crystal structure of cobalt-bound f93i/f95m/w97v carbonic anhydrase (caii) variant
K 2.1 3ni5A Carbonic anhydrase inhibitor: c1 family
K 2.1 1bnwA Carbonic anhydrase ii inhibitor
K 2.1 4e4aA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
K 2.1 5n1sA Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-(1h-indol-2-yl)-benzenesulfonamide
K 2.1 5cacA Refined structure of human carbonic anhydrase ii at 2.0 angstroms resolution
K 2.1 5tyaA Identification of a new zinc binding chemotype by fragment screening
K 2.1 2povA The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide
K 2.1 4wl4A Crystal structure of human carbonic anhydrase ii in complex with the 6-hydroxy-chromene-2-thione inhibitor
K 2.1 4itoA Human ca ii inhibition by novel sulfonamide
K 2.1 3v3jA Kinetic and structural studies of thermostabilized mutants of hca ii.
K 2.1 4fl7A The crystal structure of human carbonic anhydrase ii in complex with n-(hydroxy)-benzamide
K 2.1 1koqA Neisseria gonorrhoeae carbonic anhydrase
K 2.1 1cvhA Structural consequences of redesigning a protein-zinc binding site
K 2.1 2it4A X ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet
K 2.1 1g6vA Complex of the camelid heavy-chain antibody fragment cab-ca05 with bovine carbonic anhydrase
K 2.1 1rj6A Crystal structure of the extracellular domain of murine carbonic anhydrase xiv in complex with acetazolamide
K 2.1 1cctA Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity
K 2.1 1bnuA Carbonic anhydrase ii inhibitor
K 2.1 3m2zA Fragment tethered to carbonic anhydrase ii h64c mutant
K 2.1 6bccA Joint x-ray/neutron structure of human carbonic anhydrase ii in complex with ethoxzolamide
K 2.1 1dcbA Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch
K 2.1 4frcA Carbonic anhydrase ii in complex with n'-sulfamoylpyrrolidine-1-carboximidamide
K 2.1 1oq5A Carbonic anhydrase ii in complex with nanomolar inhibitor
K 2.1 4e3dA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
K 2.1 4pxxA Crystal structure of a highly thermal stabilized variant of human carbonic anhydrase ii
K 2.1 4r5bA Human carbonic anhydrase ii in complex with a carbohydrate-based sulfamate
K 2.1 3dcsA Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
K 2.1 2cabA Structure, refinement and function of carbonic anhydrase isozymes. refinement of human carbonic anhydrase i
K 2.1 4q6dA Crystal structure of human carbonic anhydrase isozyme ii with 4-[(z)-azepan-1-yldiazenyl]benzenesulfonamide
K 2.1 5u0eA Identification of a new zinc binding chemotype by fragment screening
K 2.1 1dcaA Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch
K 2.1 4qjxA Crystal structure of human carbonic anhydrase isozyme xiii with inhibitor
K 2.1 5gmmA Crystal structure of human carbonic anhydrase i in complex with polmacoxib
K 2.1 4yvyA Crystal structure of human carbonic anhydrase ii in complex with hydroxylamine-o-sulfonamide, a molecule incorporating two zinc-binding groups.
K 2.1 5n0dA Crystal structure of human carbonic anhydrase ii in complex with (r)-4-(6,7-dihydroxy-1-phenyl-3,4-tetrahydroisoquinoline-1h-2-carbonyl)benzenesulfonamide.
K 2.1 1cvaA Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase ii
K 2.1 1cilA The positions of his-64 and a bound water in human carbonic anhydrase ii upon binding three structurally related inhibitors
K 2.1 1tg9A Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
K 2.1 1hecA Structural consequences of hydrophilic amino-acid substitutions in the hydrophobic pocket of human carbonic anhydrase ii
K 2.1 1cvcA Redesigning the zinc binding site of human carbonic anhydrase ii: structure of a his2asp-zn2+ metal coordination polyhedron
K 2.1 1yo1A Proton transfer from his200 in human carbonic anhydrase ii
K 2.1 2nxsA Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii
K 2.1 1ydbA Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii
K 2.1 2nxrA Structural effects of hydrophobic mutations on the active site of human carbonic anhydrase ii
K 2.1 3t84A Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
K 2.1 4z1jA Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv)
K 2.1 4y0jA H/d exchanged human carbonic anhydrase ii ph 6 room temperature neutron crystal structure.
K 2.1 1fr7A X-ray crystal structure of zinc-bound f93s/f95l/w97m carbonic anhydrase (caii) variant
K 2.1 1crmA Structure and function of carbonic anhydrases
K 2.1 1fljA Crystal structure of s-glutathiolated carbonic anhydrase iii
K 2.1 1cnwA Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase ii influence binding constants
K 2.1 4q06A Crystal structure of chimeric carbonic anhydrase ix with inhibitor
K 2.1 2nn7A Structure of inhibitor binding to carbonic anhydrase i
K 2.1 3m5sA Carbonic anhydrase ii mutant h64c in complex with carbonate
K 2.1 3m1wA Carbonic anhyrdase ii mutant w5ch64c with closed disulfide bond in complex with sulfate
K 2.1 1cvdA Structural consequences of redesigning a protein-zinc binding site
K 2.1 6d1mA Design, synthesis, and x-ray of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects
K 2.1 1fsrA X-ray crystal structure of copper-bound f93s/f95l/w97m carbonic anhydrase (caii) variant
K 2.1 4m2vA Genetically engineered carbonic anhydrase ix in complex with brinzolamide
K 2.1 4k1qA Structure of hcaix mimic (hcaii with 5 mutations in active site)
K 2.1 1cnyA Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase ii influence binding constants
K 2.1 1a42A Human carbonic anhydrase ii complexed with brinzolamide
K 2.1 3v3gB Kinetic and structural studies of thermostabilized mutants of hca ii.
K 2.1 3hfpA Crystal structure of teh complex between ca ii and the activator mai
K 2.1 1cncA Compensatory plastic effects in the redesign of protein-zinc binding sites
K 2.1 2nwzA Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii
K 2.1 4hf3A Activity enhancers of h64a variant of human carbonic anhydrase ii possess multiple binding sites within and around the enzyme structure
K 2.1 3tvoX Human carbonic anhydrase ii proton transfer double mutant
K 2.1 2q38A Carbonic anhydrase ii in complex with saccharin at 1.95 angstrom
K 2.1 3kigA Mutant carbonic anhydrase ii in complex with an azide and an alkyne
K 2.1 3m2yA Carbonic anhydrase ii in complex with novel sulfonamide inhibitor
K 2.1 8ca2A Engineering the hydrophobic pocket of carbonic anhydrase ii
K 2.1 3da2A X-ray structure of human carbonic anhydrase 13 in complex with inhibitor
K 2.1 4yytA Human carbonic anhydrase ii complexed with an inhibitor with a benzenesulfonamide group (5).
K 2.1 4yxoA Human carbonic anhydrase ii complexed with an inhibitor with a benzenesulfonamide group (3).
K 2.1 2h15A Carbonic anhydrase inhibitors: clashing with ala65 as a means of designing isozyme-selective inhibitors that show low affinity for the ubiquitous isozyme ii
K 2.1 1cimA The positions of his-64 and a bound water in human carbonic anhydrase ii upon binding three structurally related inhibitors

KnotProt | Interdisciplinary Laboratory of Biological Systems Modelling